Holen Sie sich die Stockscreener-App
7.36
18.52%
1.15
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
3.457
|
- | 4.219 | 2.748 | 1.15 |
| Operating Income/Loss |
58.43%
-4.512
|
-2.848 | -5.595 | -3.382 | -1.513 |
| Nonoperating Income/Loss |
140.00%
-0.006
|
0.015 | -0.113 | 11.68 | -28.66 |
|
Net Income/Loss
|
59.48%
-4.518
|
-2.833 | -5.708 | 8.299 | -30.17 |
| Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
0.433 | 1.808 | 0.144 | 0.085 |
| Basic Average Shares |
28.19%
38.82
|
30.28 | 2.4882 | 3.9407 | 2.7718 |
| Diluted Average Shares |
28.19%
38.82
|
30.28 | 2.4882 | 3.9407 | 2.7718 |
| Basic Earnings Per Share |
9.09%
-0.12
|
-0.11 | 2.22 | 1.04 | -10.92 |
| Diluted Earnings Per Share |
9.09%
-0.12
|
-0.11 | 2.22 | 1.04 | -10.92 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):